News & Updates

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025 by

A single dose of adjuvanted respiratory syncytial virus (RSV) prefusion F protein–based vaccine (RSVPreF3 OA) is efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) over three RSV seasons in older adults aged ≥60 years, according to results of the phase III AReSVi-006 trial presented at ESCMID Global 2025.

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

04 May 2025

A strategy of upfront routine thoracentesis in addition to standard medical therapy does not appear to improve survival outcomes for patients with acute heart failure and pleural effusion, as shown in the results of TAP-IT*.

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

04 May 2025

Breastfeeding reduces risk of infant RTIs

02 May 2025

Infants who have been fully breastfed for 6 months up to at least 1 year appear to have a lower risk of subsequent respiratory tract infections (RTIs) and hospitalization from RTIs, a study has shown.

Breastfeeding reduces risk of infant RTIs

02 May 2025

MSC therapy delivers long-term benefit in severe COVID-19

02 May 2025 by

A recent study suggests patients with severe COVID-19 may benefit from human mesenchymal stem cell (MSC) therapy.

MSC therapy delivers long-term benefit in severe COVID-19

02 May 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

New drug applications approved by US FDA as of 1-15 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?

30 Apr 2025 by

In patients with treatment-naive metastatic nonsmall cell lung cancer (NSCLC), subcutaneous (SC) pembrolizumab (pembro) demonstrates comparable efficacy to that of intravenous (IV) pembro as regards overall exposure and trough concentration, reports a study presented at ELCC 2025.

SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?

30 Apr 2025

Neoadjuvant chemo plus durvalumab improves survival in NSCLC

30 Apr 2025 by

The addition of durvalumab to neoadjuvant chemotherapy with cisplatin and docetaxel results in better survival rates among patients with resectable nonsmall cell lung cancer (NSCLC), according to a study presented at ELCC 2025.

Neoadjuvant chemo plus durvalumab improves survival in NSCLC

30 Apr 2025

I-gel vs Fastrach: Which SGD is better for intubation?

30 Apr 2025 by

In a systematic review and meta-analysis comparing the I-gel and Fastrach supraglottic airway devices (SGDs) when used in adult patients requiring intubation, the latter edges out the former in terms of success rate for first-pass intubation. However, intubation success rate was better when a flexible scope was used through the I-gel.

I-gel vs Fastrach: Which SGD is better for intubation?

30 Apr 2025

OSA linked to arrhythmias during sleep in IHD patients

29 Apr 2025 by

A significant association between obstructive sleep apnoea (OSA) and nocturnal atrial fibrillation (AF)/flutter has been observed in patients with ischaemic heart disease (IHD), reveals a Singapore study.

OSA linked to arrhythmias during sleep in IHD patients

29 Apr 2025

Skin pigmentation affects pulse oximeter performance

27 Apr 2025 by

Findings from the EquiOx trial presented at ACC.25 underpin the influence of skin pigmentation in pulse oximetry.

Skin pigmentation affects pulse oximeter performance

27 Apr 2025

News & Updates

Filter by Specialty:

Specialty:

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

Breastfeeding reduces risk of infant RTIs

Breastfeeding reduces risk of infant RTIs

MSC therapy delivers long-term benefit in severe COVID-19

MSC therapy delivers long-term benefit in severe COVID-19

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?

SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?

Neoadjuvant chemo plus durvalumab improves survival in NSCLC

Neoadjuvant chemo plus durvalumab improves survival in NSCLC

I-gel vs Fastrach: Which SGD is better for intubation?

I-gel vs Fastrach: Which SGD is better for intubation?

OSA linked to arrhythmias during sleep in IHD patients

OSA linked to arrhythmias during sleep in IHD patients

Skin pigmentation affects pulse oximeter performance

Skin pigmentation affects pulse oximeter performance